New - European Medical Journal

Continue

News

Oncology
1 Dec 2017

New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer Patient Populations

Irvine, CA, USA and Amsterdam, the Netherlands, 30 November, 2017 – Agendia, Inc., a world leader in personalized medicine…
Oncology
1 Dec 2017

Eye Contact Establishes Brainwave Synchronisation Between Adults and Babies

BRAINWAVES of adults and babies are synchronised when eye contact is made between the two, which is likely to enhance communication and learning…
Gastroenterology
30 Nov 2017

Protein from a Worm Parasite Could Provide New Treatments for Inflammatory Bowel Diseases

A PROTEIN from a worm parasite could provide the basis for future treatment options for inflammatory bowel diseases, according to researchers at the…
Innovations
30 Nov 2017

New Generation of Remote-Controlled Nanorobots Developed

NANOROBOTS that have the potential to diagnose disease and deliver drugs from within the human body have been created by a team of researchers…
General Healthcare
30 Nov 2017

Introducing the European Medical Journal 2.4

United Kingdom, November 30, 2017: The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4.
General Healthcare
30 Nov 2017

Potential

Way back at the beginning of the year, when I was asked to create content and a schedule for the Future Leaders blog posts, I decided that I would write…
Innovations
30 Nov 2017

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials
Oncology
30 Nov 2017

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…